Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 202 articles:
HTML format
Text format



Single Articles


    April 2017
  1. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Text format     Abstract available


    March 2017
  2. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Text format     Abstract available


  3. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Text format     Abstract available


  4. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Text format     Abstract available


  5. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Text format     Abstract available


  6. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Text format     Abstract available


  7. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Text format     Abstract available


  8. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Text format     Abstract available


  9. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Text format     Abstract available


  10. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Text format     Abstract available


  11. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Text format     Abstract available


  12. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.
    PubMed     Text format    


  13. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Text format     Abstract available


    February 2017
  14. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Text format     Abstract available


  15. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Text format     Abstract available


  16. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Text format     Abstract available


  17. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Text format     Abstract available


  18. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed     Text format    


  19. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Text format     Abstract available


  20. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Text format     Abstract available


  21. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Text format     Abstract available


  22. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Text format     Abstract available


  23. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Text format     Abstract available


  24. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Text format     Abstract available


    January 2017
  25. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Text format     Abstract available


  26. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.
    PubMed     Text format    


  27. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Text format     Abstract available


  28. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Text format     Abstract available


  29. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Text format     Abstract available



  30. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Text format     Abstract available


    December 2016
  31. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Text format     Abstract available


  32. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Text format     Abstract available


  33. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Text format     Abstract available


  34. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Text format     Abstract available


    November 2016
  35. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Text format     Abstract available


  36. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Text format     Abstract available


  37. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Text format     Abstract available


  38. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.
    PubMed     Text format    


    October 2016
  39. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Text format     Abstract available


  40. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Text format     Abstract available


  41. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Text format     Abstract available


  42. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Text format     Abstract available


  43. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Text format     Abstract available


  44. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Text format     Abstract available


    September 2016
  45. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Text format     Abstract available


  46. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Text format     Abstract available


  47. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Text format     Abstract available


  48. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Text format     Abstract available


  49. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Text format     Abstract available


  50. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Text format     Abstract available


  51. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Text format     Abstract available


  52. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Text format     Abstract available


  53. LANCTOT KL, Boot BP, Bain LJ, Hendrix JA, et al
    Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease.
    Alzheimers Dement. 2016;12:1031-2.
    PubMed     Text format    


    August 2016
  54. BATEMAN RJ, Benzinger TL, Berry S, Clifford DB, et al
    The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
    Alzheimers Dement. 2016 Aug 29. pii: S1552-5260(16)30048.
    PubMed     Text format     Abstract available


  55. SARRO L, Tosakulwong N, Schwarz CG, Graff-Radford J, et al
    An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.
    Alzheimers Dement. 2016 Aug 10. pii: S1552-5260(16)32682.
    PubMed     Text format     Abstract available


  56. SONG W, Hooli B, Mullin K, Jin SC, et al
    Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.
    Alzheimers Dement. 2016 Aug 9. pii: S1552-5260(16)30203.
    PubMed     Text format     Abstract available


  57. THEOFILAS P, Ehrenberg AJ, Dunlop S, Alho AT, et al
    Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
    Alzheimers Dement. 2016 Aug 8. pii: S1552-5260(16)32679.
    PubMed     Text format     Abstract available


    July 2016
  58. TAYLOR AN, Kambeitz-Ilankovic L, Gesierich B, Simon-Vermot L, et al
    Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease.
    Alzheimers Dement. 2016 Jul 15. pii: S1552-5260(16)32660.
    PubMed     Text format     Abstract available


  59. GISPERT JD, Suarez-Calvet M, Monte GC, Tucholka A, et al
    Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.
    Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30026.
    PubMed     Text format     Abstract available


  60. COLEY N, Gallini A, Ousset PJ, Vellas B, et al
    Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial.
    Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30085.
    PubMed     Text format     Abstract available


    June 2016
  61. SNYDER PJ
    DADM: The first 2 years of the Alzheimer Association's open access journal to support the research and development of novel biomarkers and diagnostic approaches.
    Alzheimers Dement. 2016 Jun 28. pii: S1552-5260(16)30310.
    PubMed     Text format    


  62. SOBOL NA, Hoffmann K, Frederiksen KS, Vogel A, et al
    Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.
    Alzheimers Dement. 2016 Jun 23. pii: S1552-5260(15)30002.
    PubMed     Text format     Abstract available


  63. CACERES A, Vargas JE, Gonzalez JR
    APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects.
    Alzheimers Dement. 2016 Jun 20. pii: S1552-5260(16)30283.
    PubMed     Text format     Abstract available


  64. HERRING A, Munster Y, Akkaya T, Moghaddam S, et al
    Kallikrein-8 inhibition attenuates Alzheimer's pathology in mice.
    Alzheimers Dement. 2016 Jun 18. pii: S1552-5260(16)30280.
    PubMed     Text format     Abstract available


  65. SUN X, Dong C, Levin B, Crocco E, et al
    APOE epsilon4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.
    Alzheimers Dement. 2016 Jun 16. pii: S1552-5260(16)30278.
    PubMed     Text format     Abstract available


  66. SNYDER HM, Cardenas-Aguayo Mdel C, Alonso A, Bain L, et al
    Alzheimer's disease research in Ibero America.
    Alzheimers Dement. 2016;12:749-54.
    PubMed     Text format    


    May 2016
  67. GEERTS H, Dacks PA, Devanarayan V, Haas M, et al
    From big data to smart data in Alzheimer's disease. The brain health modeling initiative to foster actionable knowledge.
    Alzheimers Dement. 2016 May 26. pii: S1552-5260(16)30246.
    PubMed     Text format     Abstract available


  68. SHI M, Kovac A, Korff A, Cook TJ, et al
    CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease.
    Alzheimers Dement. 2016 May 24. pii: S1552-5260(16)30242.
    PubMed     Text format     Abstract available


  69. BERECZKI E, Francis PT, Howlett D, Pereira JB, et al
    Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.
    Alzheimers Dement. 2016 May 22. pii: S1552-5260(16)30244.
    PubMed     Text format     Abstract available


  70. CALSOLARO V, Edison P
    Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
    Alzheimers Dement. 2016 May 11. pii: S1552-5260(16)30185.
    PubMed     Text format     Abstract available


  71. ROSES A, Sundseth S, Saunders A, Gottschalk W, et al
    Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease.
    Alzheimers Dement. 2016 May 3. pii: S1552-5260(16)30118.
    PubMed     Text format     Abstract available


  72. PRIOR M, Goldberg J, Chiruta C, Farrokhi C, et al
    Selecting for neurogenic potential as an alternative for Alzheimer's drug discovery.
    Alzheimers Dement. 2016 May 2. pii: S1552-5260(16)30117.
    PubMed     Text format     Abstract available


  73. WENINGER S, Carrillo MC, Dunn B, Aisen PS, et al
    Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
    Alzheimers Dement. 2016;12:631-2.
    PubMed     Text format    


    April 2016
  74. TOSUN D, Chen YF, Yu P, Sundell KL, et al
    Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort.
    Alzheimers Dement. 2016 Apr 21. pii: S1552-5260(16)30192.
    PubMed     Text format     Abstract available


  75. GRAFF-RADFORD NR, Besser LM, Crook JE, Kukull WA, et al
    Neuropathologic differences by race from the National Alzheimer's Coordinating Center.
    Alzheimers Dement. 2016 Apr 16. pii: S1552-5260(16)30182.
    PubMed     Text format     Abstract available


  76. ALLEN GI, Amoroso N, Anghel C, Balagurusamy V, et al
    Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.
    Alzheimers Dement. 2016 Apr 11. pii: S1552-5260(16)00081.
    PubMed     Text format     Abstract available


  77. RABINOVICI GD, Karlawish J, Knopman D, Snyder HM, et al
    Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
    Alzheimers Dement. 2016;12:510-5.
    PubMed     Text format     Abstract available



  78. 2016 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2016;12:459-509.
    PubMed     Text format     Abstract available


  79. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Text format     Abstract available


  80. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Text format     Abstract available


    March 2016
  81. HENDRIX JA, Bateman RJ, Brashear HR, Duggan C, et al
    Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
    Alzheimers Dement. 2016 Mar 24. pii: S1552-5260(16)00082.
    PubMed     Text format     Abstract available


  82. CACACE R, Sleegers K, Van Broeckhoven C
    Molecular genetics of early-onset Alzheimer disease revisited.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00079.
    PubMed     Text format     Abstract available


  83. YU L, Chibnik L, Yang J, McCabe C, et al
    Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00084.
    PubMed     Text format     Abstract available


  84. GREEN C, Zhang S
    Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00078.
    PubMed     Text format     Abstract available


  85. SCHOTT JM, Crutch SJ, Carrasquillo MM, Uphill J, et al
    Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.
    Alzheimers Dement. 2016 Mar 15. pii: S1552-5260(16)00077.
    PubMed     Text format     Abstract available


  86. DI STEFANO F, Kas A, Habert MO, Decazes P, et al
    The phenotypical core of Alzheimer-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study.
    Alzheimers Dement. 2016 Mar 14. pii: S1552-5260(16)00075.
    PubMed     Text format     Abstract available


  87. MOLINUEVO JL, Cami J, Carne X, Carrillo MC, et al
    Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.
    Alzheimers Dement. 2016 Mar 14. pii: S1552-5260(16)00076.
    PubMed     Text format     Abstract available


  88. DUBOIS B, Hampel H, Feldman HH, Scheltens P, et al
    Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
    Alzheimers Dement. 2016;12:292-323.
    PubMed     Text format     Abstract available


  89. KHACHATURIAN ZS, Mesulam MM, Mohs RC, Khachaturian AS, et al
    Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?
    Alzheimers Dement. 2016;12:213-5.
    PubMed     Text format    


    February 2016
  90. RUIZ HH, Chi T, Lindtner C, Hsieh W, et al
    Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels.
    Alzheimers Dement. 2016 Feb 26. pii: S1552-5260(16)00049.
    PubMed     Text format     Abstract available


  91. LOUWERSHEIMER E, Wolfsgruber S, Espinosa A, Lacour A, et al
    Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment.
    Alzheimers Dement. 2016 Feb 24. pii: S1552-5260(16)00046.
    PubMed     Text format     Abstract available


  92. THOMAS RG, Albert M, Petersen RC, Aisen PS, et al
    Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials.
    Alzheimers Dement. 2016 Feb 22. pii: S1552-5260(16)00032.
    PubMed     Text format     Abstract available


  93. BROOKMEYER R, Kawas CH, Abdallah N, Paganini-Hill A, et al
    Impact of interventions to reduce Alzheimer disease pathology on the prevalence of dementia in the oldest-old.
    Alzheimers Dement. 2016 Feb 17. pii: S1552-5260(16)00034.
    PubMed     Text format     Abstract available


  94. SANDER K, Lashley T, Gami P, Gendron T, et al
    Characterization of tau positron emission tomography tracer [F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias.
    Alzheimers Dement. 2016 Feb 15. pii: S1552-5260(16)00033.
    PubMed     Text format     Abstract available


  95. BORSON S, Boustani MA, Buckwalter KC, Burgio LD, et al
    Report on milestones for care and support under the U.S. National Plan to Address Alzheimer's Disease.
    Alzheimers Dement. 2016 Feb 8. pii: S1552-5260(16)00035.
    PubMed     Text format     Abstract available


  96. BUCKLEY RF, Maruff P, Ames D, Bourgeat P, et al
    Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.
    Alzheimers Dement. 2016 Feb 4. pii: S1552-5260(16)00015.
    PubMed     Text format     Abstract available


  97. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Text format     Abstract available


  98. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Text format     Abstract available


    January 2016
  99. ABNER EL, Nelson PT, Kryscio RJ, Schmitt FA, et al
    Diabetes is associated with cerebrovascular but not Alzheimer neuropathology.
    Alzheimers Dement. 2016 Jan 23. pii: S1552-5260(15)03030.
    PubMed     Text format     Abstract available


  100. PODLESNIY P, Llorens F, Golanska E, Sikorska B, et al
    Mitochondrial DNA differentiates Alzheimer from Creutzfeldt-Jakob disease.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03035.
    PubMed     Text format     Abstract available


  101. KELLER A, Backes C, Haas J, Leidinger P, et al
    Validating Alzheimer's disease micro RNAs using next-generation sequencing.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03036.
    PubMed     Text format     Abstract available


  102. CLARK LR, Racine AM, Koscik RL, Okonkwo OC, et al
    Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03033.
    PubMed     Text format     Abstract available


  103. CASANOVA R, Varma S, Simpson B, Kim M, et al
    Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03032.
    PubMed     Text format     Abstract available


  104. DE WILDE MC, Overk CR, Sijben JW, Masliah E, et al
    Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.
    Alzheimers Dement. 2016 Jan 14. pii: S1552-5260(15)03029.
    PubMed     Text format     Abstract available


  105. HONDIUS DC, van Nierop P, Li KW, Hoozemans JJ, et al
    Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.
    Alzheimers Dement. 2016 Jan 6. pii: S1552-5260(15)02987.
    PubMed     Text format     Abstract available


  106. GAUTHIER S, Albert M, Fox N, Goedert M, et al
    Why has therapy development for dementia failed in the last two decades?
    Alzheimers Dement. 2016;12:60-4.
    PubMed     Text format     Abstract available


  107. PANNEE J, Gobom J, Shaw LM, Korecka M, et al
    Round robin test on quantification of amyloid-beta 1-42 in cerebrospinal fluid by mass spectrometry.
    Alzheimers Dement. 2016;12:55-9.
    PubMed     Text format     Abstract available


  108. GORDON MF, Lenderking WR, Duhig A, Chandler J, et al
    Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.
    Alzheimers Dement. 2016;12:75-84.
    PubMed     Text format     Abstract available


    December 2015
  109. LEVY NOGUEIRA M, Epelbaum S, Steyaert JM, Dubois B, et al
    Mechanical stress models of Alzheimer's disease pathology.
    Alzheimers Dement. 2015 Dec 21. pii: S1552-5260(15)02952.
    PubMed     Text format     Abstract available


  110. ROLLO JL, Banihashemi N, Vafaee F, Crawford JW, et al
    Unraveling the mechanistic complexity of Alzheimer's disease through systems biology.
    Alzheimers Dement. 2015 Dec 15. pii: S1552-5260(15)02985.
    PubMed     Text format     Abstract available


    November 2015
  111. ZHANG C, Kuo CC, Moghadam SH, Monte L, et al
    Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2015 Nov 7. pii: S1552-5260(15)02913.
    PubMed     Text format     Abstract available


  112. KHACHATURIAN ZS, Mesulam MM, Khachaturian AS, Mohs RC, et al
    The Special Topics Section of Alzheimer's & Dementia.
    Alzheimers Dement. 2015;11:1261-4.
    PubMed     Text format    


    October 2015
  113. ANDRIEU S, Coley N, Rolland Y, Cantet C, et al
    Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives.
    Alzheimers Dement. 2015 Oct 23. pii: S1552-5260(15)02904.
    PubMed     Text format     Abstract available


  114. EBBERT MT, Boehme KL, Wadsworth ME, Staley LA, et al
    Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
    Alzheimers Dement. 2015 Oct 5. pii: S1552-5260(15)02866.
    PubMed     Text format     Abstract available


    September 2015
  115. BARRAL S, Cheng R, Reitz C, Vardarajan B, et al
    Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2015 Sep 30. pii: S1552-5260(15)02650.
    PubMed     Text format     Abstract available


  116. KUNKLE BW, Jaworski J, Barral S, Vardarajan B, et al
    Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2015 Sep 10. pii: S1552-5260(15)00224.
    PubMed     Text format     Abstract available


  117. HUBIN E, Vanschoenwinkel B, Broersen K, De Deyn PP, et al
    Could ecosystem management provide a new framework for Alzheimer's disease?
    Alzheimers Dement. 2015 Sep 1. pii: S1552-5260(15)02668.
    PubMed     Text format     Abstract available


  118. LEHMANN S, Gabelle A, Paquet C
    Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?
    Alzheimers Dement. 2015;11:1125-6.
    PubMed     Text format    


    August 2015
  119. MONTINE TJ, Monsell SE, Beach TG, Bigio EH, et al
    Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Alzheimers Dement. 2015 Aug 29. pii: S1552-5260(15)02669.
    PubMed     Text format     Abstract available


  120. TOGA AW, Neu SC, Bhatt P, Crawford KL, et al
    The Global Alzheimer's Association Interactive Network.
    Alzheimers Dement. 2015 Aug 25. pii: S1552-5260(15)02651.
    PubMed     Text format     Abstract available


  121. HYMAN BT, Growdon JH, Albers MW, Buckner RL, et al
    Massachusetts Alzheimer's Disease Research Center: Progress and challenges.
    Alzheimers Dement. 2015 Aug 19. pii: S1552-5260(15)02124.
    PubMed     Text format    


    July 2015
  122. SIEMERS ER, Sundell KL, Carlson C, Case M, et al
    Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
    Alzheimers Dement. 2015 Jul 31. pii: S1552-5260(15)02148.
    PubMed     Text format     Abstract available


  123. RAMIREZ J, McNeely AA, Scott CJ, Masellis M, et al
    White matter hyperintensity burden in elderly cohort studies. The Sunnybrook Dementia Study, Alzheimer Disease Neuroimaging Initiative, and Three-City Study.
    Alzheimers Dement. 2015 Jul 21. pii: S1552-5260(15)02123.
    PubMed     Text format     Abstract available


  124. HUNTER CA, Kirson NY, Desai U, Cummings AK, et al
    Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries.
    Alzheimers Dement. 2015 Jul 20. pii: S1552-5260(15)02126.
    PubMed     Text format     Abstract available


  125. AGADJANYAN MG, Petrovsky N, Ghochikyan A
    A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease.
    Alzheimers Dement. 2015 Jul 17. pii: S1552-5260(15)02121.
    PubMed     Text format     Abstract available


  126. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
    Alzheimers Dement. 2015;11:865-84.
    PubMed     Text format     Abstract available


  127. JONES-DAVIS DM, Buckholtz N
    The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
    Alzheimers Dement. 2015;11:860-4.
    PubMed     Text format     Abstract available


  128. HENDRIX JA, Finger B, Weiner MW, Frisoni GB, et al
    The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
    Alzheimers Dement. 2015;11:850-9.
    PubMed     Text format     Abstract available


  129. LIU E, Luthman J, Cedarbaum JM, Schmidt ME, et al
    Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
    Alzheimers Dement. 2015;11:840-9.
    PubMed     Text format     Abstract available


  130. TOGA AW, Crawford KL
    The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review.
    Alzheimers Dement. 2015;11:832-9.
    PubMed     Text format     Abstract available


  131. BECKETT LA, Donohue MC, Wang C, Aisen P, et al
    The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.
    Alzheimers Dement. 2015;11:823-31.
    PubMed     Text format     Abstract available


  132. FRANKLIN EE, Perrin RJ, Vincent B, Baxter M, et al
    Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.
    Alzheimers Dement. 2015;11:815-22.
    PubMed     Text format     Abstract available


  133. KANG JH, Korecka M, Figurski MJ, Toledo JB, et al
    The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
    Alzheimers Dement. 2015;11:772-91.
    PubMed     Text format     Abstract available


  134. JAGUST WJ, Landau SM, Koeppe RA, Reiman EM, et al
    The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
    Alzheimers Dement. 2015;11:757-71.
    PubMed     Text format     Abstract available


  135. JACK CR JR, Barnes J, Bernstein MA, Borowski BJ, et al
    Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
    Alzheimers Dement. 2015;11:740-56.
    PubMed     Text format     Abstract available


  136. AISEN PS, Petersen RC, Donohue M, Weiner MW, et al
    Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans.
    Alzheimers Dement. 2015;11:734-9.
    PubMed     Text format     Abstract available


  137. WEINER MW, Veitch DP
    Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2015;11:730-3.
    PubMed     Text format     Abstract available


  138. THIES WH
    Alzheimer's Disease Neuroimaging Initiative: A decade of progress in Alzheimer's disease.
    Alzheimers Dement. 2015;11:727-9.
    PubMed     Text format    


    June 2015
  139. THAL DR, Beach TG, Zanette M, Heurling K, et al
    [F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-beta pathology.
    Alzheimers Dement. 2015 Jun 30. pii: S1552-5260(15)00216.
    PubMed     Text format     Abstract available


  140. LIU H, Qiu H, Yang J, Ni J, et al
    Chronic hypoxia facilitates Alzheimer's disease through demethylation of gamma-secretase by downregulating DNA methyltransferase 3b.
    Alzheimers Dement. 2015 Jun 26. pii: S1552-5260(15)00217.
    PubMed     Text format     Abstract available


  141. HOHMAN TJ, Cooke-Bailey JN, Reitz C, Jun G, et al
    Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.
    Alzheimers Dement. 2015 Jun 16. pii: S1552-5260(15)00190.
    PubMed     Text format     Abstract available


  142. DE VOS A, Jacobs D, Struyfs H, Fransen E, et al
    C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
    Alzheimers Dement. 2015 Jun 16. pii: S1552-5260(15)00181.
    PubMed     Text format     Abstract available


  143. LEVY NOGUEIRA M, Lafitte O, Steyaert JM, Bakardjian H, et al
    Mechanical stress related to brain atrophy in Alzheimer's disease.
    Alzheimers Dement. 2015 Jun 15. pii: S1552-5260(15)00196.
    PubMed     Text format     Abstract available


  144. SLEEGERS K, Bettens K, De Roeck A, Cauwenberghe CV, et al
    A 22-single nucleotide polymorphism Alzheimer risk score correlates with family history, onset age, and cerebrospinal fluid Abeta.
    Alzheimers Dement. 2015 Jun 15. pii: S1552-5260(15)00191.
    PubMed     Text format     Abstract available


  145. MUKHERJEE S, Walter S, Kauwe JS, Saykin AJ, et al
    Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00184.
    PubMed     Text format     Abstract available


  146. ROSEN C, Farahmand B, Skillback T, Nagga K, et al
    Benchmarking biomarker-based criteria for Alzheimer's disease-Data from the Swedish Dementia Registry, SveDem.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00185.
    PubMed     Text format     Abstract available


  147. NORDESTGAARD LT, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, et al
    Loss-of-function mutation in ABCA1 and risk of Alzheimer and cerebrovascular disease.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00180.
    PubMed     Text format     Abstract available


  148. LUTZ MW, Saul R, Linnertz C, Glenn OC, et al
    A CT-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00179.
    PubMed     Text format     Abstract available


  149. HANDELS RL, Joore MA, Tran-Duy A, Wimo A, et al
    Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment.
    Alzheimers Dement. 2015 Jun 9. pii: S1552-5260(15)00176.
    PubMed     Text format     Abstract available


  150. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Alzheimers Dement. 2015;11:e1-e120.
    PubMed     Text format     Abstract available


    May 2015
  151. RISACHER SL, Kim S, Nho K, Foroud T, et al
    APOE effect on Alzheimer's biomarkers in older adults with significant memory concern.
    Alzheimers Dement. 2015 May 7. pii: S1552-5260(15)00124.
    PubMed     Text format     Abstract available


  152. PASQUINI L, Scherr M, Tahmasian M, Meng C, et al
    Link between hippocampus' raised local and eased global intrinsic connectivity in AD.
    Alzheimers Dement. 2015;11:475-84.
    PubMed     Text format     Abstract available


    April 2015
  153. LILL CM, Rengmark A, Pihlstrom L, Fogh I, et al
    The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
    Alzheimers Dement. 2015 Apr 29. pii: S1552-5260(15)00122.
    PubMed     Text format     Abstract available


  154. FRIGERIO CS, Lau P, Troakes C, Deramecourt V, et al
    On the identification of low allele frequency mosaic mutations in the brains of Alzheimer disease patients.
    Alzheimers Dement. 2015 Apr 28. pii: S1552-5260(15)00120.
    PubMed     Text format     Abstract available


  155. BARNES J, Dickerson B, Frost C, Jiskoot LC, et al
    Alzheimer's disease first symptoms are age dependent: Evidence from the NACC data set.
    Alzheimers Dement. 2015 Apr 24. pii: S1552-5260(15)00117.
    PubMed     Text format     Abstract available


  156. KODAMULLIL AT, Younesi E, Naz M, Bagewadi S, et al
    Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis.
    Alzheimers Dement. 2015 Apr 4. pii: S1552-5260(15)00083.
    PubMed     Text format     Abstract available


  157. SABBAGH MN, Chen K, Rogers J, Fleisher AS, et al
    Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
    Alzheimers Dement. 2015 Apr 4. pii: S1552-5260(15)00084.
    PubMed     Text format     Abstract available


  158. MC DONALD JM, O'Malley TT, Liu W, Mably AJ, et al
    The aqueous phase of Alzheimer's disease brain contains assemblies built from approximately 4 and approximately 7 kDa Abeta species.
    Alzheimers Dement. 2015 Apr 3. pii: S1552-5260(15)00062.
    PubMed     Text format     Abstract available


  159. DODEL R, Belger M, Reed C, Wimo A, et al
    Determinants of societal costs in Alzheimer's disease: GERAS study baseline results.
    Alzheimers Dement. 2015 Apr 3. pii: S1552-5260(15)00082.
    PubMed     Text format     Abstract available


  160. HUANG Y, Ito K, Billing CB Jr, Anziano RJ, et al
    Development of a straightforward and sensitive scale for MCI and early AD clinical trials.
    Alzheimers Dement. 2015;11:404-14.
    PubMed     Text format     Abstract available


    March 2015
  161. SABRI O, Sabbagh MN, Seibyl J, Barthel H, et al
    Florbetaben PET imaging to detect amyloid plaques in Alzheimer disease: Phase 3 study.
    Alzheimers Dement. 2015 Mar 27. pii: S1552-5260(15)00060.
    PubMed     Text format     Abstract available


  162. EWERS M, Mattsson N, Minthon L, Molinuevo JL, et al
    CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study.
    Alzheimers Dement. 2015 Mar 21. pii: S1552-5260(15)00063.
    PubMed     Text format     Abstract available


  163. ZEA-SEVILLA MA, Fernandez-Blazquez MA, Calero M, Bermejo-Velasco P, et al
    Combined Alzheimer and cerebrovascular staging explains advanced dementia cognition.
    Alzheimers Dement. 2015 Mar 21. pii: S1552-5260(15)00059.
    PubMed     Text format     Abstract available


  164. VAUDANO E, Vannieuwenhuyse B, Van Der Geyten S, van der Lei J, et al
    Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.
    Alzheimers Dement. 2015 Mar 6. pii: S1552-5260(15)00057.
    PubMed     Text format    



  165. 2015 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2015;11:332-84.
    PubMed     Text format     Abstract available


    February 2015
  166. MORRIS MC, Tangney CC, Wang Y, Sacks FM, et al
    MIND diet associated with reduced incidence of Alzheimer's disease.
    Alzheimers Dement. 2015 Feb 11. pii: S1552-5260(15)00017.
    PubMed     Text format     Abstract available


  167. KARAMI A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, et al
    Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Alzheimers Dement. 2015 Feb 9. pii: S1552-5260(15)00007.
    PubMed     Text format     Abstract available


  168. NEVILLE J, Kopko S, Broadbent S, Aviles E, et al
    Development of a unified clinical trial database for Alzheimer's disease.
    Alzheimers Dement. 2015 Feb 9. pii: S1552-5260(15)00004.
    PubMed     Text format     Abstract available


  169. FRISONI GB, Jack CR
    HarP: the EADC-ADNI Harmonized Protocol for manual hippocampal segmentation. A standard of reference from a global working group.
    Alzheimers Dement. 2015;11:107-10.
    PubMed     Text format    


  170. APOSTOLOVA LG, Zarow C, Biado K, Hurtz S, et al
    Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.
    Alzheimers Dement. 2015;11:139-50.
    PubMed     Text format     Abstract available


  171. DUCHESNE S, Valdivia F, Robitaille N, Mouiha A, et al
    Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project.
    Alzheimers Dement. 2015;11:161-74.
    PubMed     Text format     Abstract available


  172. BOCCARDI M, Bocchetta M, Morency FC, Collins DL, et al
    Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Alzheimers Dement. 2015;11:175-83.
    PubMed     Text format     Abstract available


  173. FRISONI GB, Jack CR Jr, Bocchetta M, Bauer C, et al
    The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.
    Alzheimers Dement. 2015;11:111-25.
    PubMed     Text format     Abstract available


  174. BOCCHETTA M, Boccardi M, Ganzola R, Apostolova LG, et al
    Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project.
    Alzheimers Dement. 2015;11:151-60.
    PubMed     Text format     Abstract available


  175. BOCCHETTA M, Galluzzi S, Kehoe PG, Aguera E, et al
    The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
    Alzheimers Dement. 2015;11:195-206.
    PubMed     Text format     Abstract available


  176. BOCCARDI M, Bocchetta M, Apostolova LG, Barnes J, et al
    Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance.
    Alzheimers Dement. 2015;11:126-38.
    PubMed     Text format     Abstract available


  177. DAIELLO LA, Gongvatana A, Dunsiger S, Cohen RA, et al
    Association of fish oil supplement use with preservation of brain volume and cognitive function.
    Alzheimers Dement. 2015;11:226-35.
    PubMed     Text format     Abstract available


  178. BOCCARDI M, Bocchetta M, Ganzola R, Robitaille N, et al
    Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation.
    Alzheimers Dement. 2015;11:184-94.
    PubMed     Text format     Abstract available


    January 2015
  179. DUBOIS B, Chupin M, Hampel H, Lista S, et al
    Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease.
    Alzheimers Dement. 2015 Jan 14. pii: S1552-5260(14)02856.
    PubMed     Text format     Abstract available



  180. Alzheimers Association update.
    Alzheimers Dement. 2015;11:104-5.
    PubMed     Text format    


  181. KLUNK WE, Koeppe RA, Price JC, Benzinger TL, et al
    The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
    Alzheimers Dement. 2015;11:1-15.
    PubMed     Text format     Abstract available


    December 2014

  182. Convergent genetic and expression data implicate immunity in Alzheimer's disease.
    Alzheimers Dement. 2014 Dec 19. pii: S1552-5260(14)02492.
    PubMed     Text format     Abstract available


  183. KVARTSBERG H, Duits FH, Ingelsson M, Andreasen N, et al
    Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
    Alzheimers Dement. 2014 Dec 19. pii: S1552-5260(14)02863.
    PubMed     Text format     Abstract available


  184. HARTLEY D, Blumenthal T, Carrillo M, DiPaolo G, et al
    Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Alzheimers Dement. 2014 Dec 12. pii: S1552-5260(14)02860.
    PubMed     Text format     Abstract available


  185. SNYDER HM, Corriveau RA, Craft S, Faber JE, et al
    Vascular contributions to cognitive impairment and dementia including Alzheimer's disease.
    Alzheimers Dement. 2014 Dec 12. pii: S1552-5260(14)02862.
    PubMed     Text format     Abstract available


  186. TOLPPANEN AM, Taipale H, Purmonen T, Koponen M, et al
    Hospital admissions, outpatient visits and healthcare costs of community-dwellers with Alzheimer's disease.
    Alzheimers Dement. 2014 Dec 10. pii: S1552-5260(14)02858.
    PubMed     Text format     Abstract available


  187. LANCASTER TM, Brindley LM, Tansey KE, Sims RC, et al
    Alzheimer's risk variant in CLU is associated with neural inefficiency in healthy individuals.
    Alzheimers Dement. 2014 Dec 10. pii: S1552-5260(14)02867.
    PubMed     Text format     Abstract available


  188. ROUSSOS P, Katsel P, Fam P, Tan W, et al
    The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia.
    Alzheimers Dement. 2014 Dec 9. pii: S1552-5260(14)02868.
    PubMed     Text format     Abstract available


  189. GREEN RC, Christensen KD, Cupples LA, Relkin NR, et al
    A randomized non-inferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
    Alzheimers Dement. 2014 Dec 9. pii: S1552-5260(14)02870.
    PubMed     Text format     Abstract available


  190. DIOMEDI M, Diomedi M, Stefani A
    Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Abeta1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al.
    Alzheimers Dement. 2014 Dec 5. pii: S1552-5260(14)02857.
    PubMed     Text format    


    November 2014
  191. RUEDA AD, Lau KM, Saito N, Harvey D, et al
    Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease.
    Alzheimers Dement. 2014 Nov 15. pii: S1552-5260(14)02823.
    PubMed     Text format     Abstract available


  192. VARLEY J, Brooks DJ, Edison P
    Imaging neuroinflammation in Alzheimer's and other dementias: Recent advances and future directions.
    Alzheimers Dement. 2014 Nov 15. pii: S1552-5260(14)02820.
    PubMed     Text format     Abstract available


  193. LASKE C, Sohrabi HR, Frost SM, Lopez-de-Ipina K, et al
    Innovative diagnostic tools for early detection of Alzheimer's disease.
    Alzheimers Dement. 2014 Nov 15. pii: S1552-5260(14)02463.
    PubMed     Text format     Abstract available


  194. SNYDER PJ, Kahle-Wrobleski K, Brannan S, Miller DS, et al
    Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?
    Alzheimers Dement. 2014;10:853-60.
    PubMed     Text format     Abstract available


    October 2014
  195. BENEDICT C, Byberg L, Cedernaes J, Hogenkamp PS, et al
    Self-reported sleep disturbance is associated with Alzheimer's disease risk in men.
    Alzheimers Dement. 2014 Oct 27. pii: S1552-5260(14)02819.
    PubMed     Text format     Abstract available


    July 2014
  196. WOLZ R, Schwarz AJ, Yu P, Cole PE, et al
    Robustness of automated hippocampal volumetry across magnetic resonance field strengths and repeat images.
    Alzheimers Dement. 2014;10:430-8.
    PubMed     Text format     Abstract available


  197. CHINCARINI A, Bosco P, Gemme G, Esposito M, et al
    Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study.
    Alzheimers Dement. 2014;10:456-67.
    PubMed     Text format     Abstract available


    June 2014
  198. WEINER MW
    Military Risk Supplement. Preface.
    Alzheimers Dement. 2014;10.
    PubMed     Text format    


  199. TANNER CM, Goldman SM, Ross GW, Grate SJ, et al
    The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk.
    Alzheimers Dement. 2014;10.
    PubMed     Text format     Abstract available


    May 2014
  200. OREMUS M
    Does the evidence say a 4-point change in ADAS-cog score is clinically significant?
    Alzheimers Dement. 2014;10:416-7.
    PubMed     Text format    


    March 2014
  201. SNYDER PJ, Lim YY, Schindler R, Ott BR, et al
    Microdosing of scopolamine as a "cognitive stress test": rationale and test of a very low dose in an at-risk cohort of older adults.
    Alzheimers Dement. 2014;10:262-7.
    PubMed     Text format     Abstract available


  202. PEDRAZA O, Allen M, Jennette K, Carrasquillo M, et al
    Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
    Alzheimers Dement. 2014;10:205-13.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: